Clinical Trial

Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The baseline infusion rate during surgery for pediatric patients still is the 'Holliday and Segar' rule (also known as the 4/2/1 rule) The question arises if this rule is not outdated, since it was calculated based on the caloric need of the pediatric population, calculated for cow milk. The study tends to validate the use of bio impedance measurements for registering fluid shifts in the pediatric surgical patients.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-02-01; most recent amendment 2025-03-04.
Status change: Not Yet Recruiting → Recruiting 2022-04-19
Trial Details
NCT Number NCT05220709
Lead Sponsor University Hospital, Antwerp
Conditions Fluid and Electrolyte Imbalance, Body Weight Changes, Children, Only
Enrollment 100 participants
Start Date 2022-04-05
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-05